AAB Research
Nottingham
About AAB Research
AAB Research is creating engineered extracellular vesicles as a scalable and affordable substitute for CAR T-cell therapy in the treatment of B-cell lymphoma.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $13.6K
- Last round: Grant (Jun 2025)
- Website: aab-research.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Medical
Canonical: https://fsome.com/organization/aab-research-139835 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.